Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Shanghai Fosun Pharmaceutical Group Co., Ltd.    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL GROUP CO.,

(600196)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Shanghai Fosun Pharmaceuti
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 5 areas of activities:

- research, development and manufacturing of medicines (74.9% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases;

- sale of medical equipments and diagnosis products (14.7%);

- medical and hospital services (10.3%);

- other (0.1%).

China accounts for 76.1% of net sales.

Number of employees : 31 370 people.
Sales per Business
20182019Delta
CNY (in Million)%CNY (in Million)%
Pharmaceutical Manufacturing and Research and Development18,68175.7%21,76676.8% +16.51%
Medical Devices and Medical Diagnostics3,63914.8%3,73613.2% +2.66%
Medical Services2,56310.4%3,04010.7% +18.61%
Others35.090.1%43.540.2% +24.09%
Sales per region
20182019Delta
CNY (in Million)%CNY (in Million)%
China19,01277.1%21,96377.5% +15.52%
Other Countries5,90623.9%6,62223.4% +12.12%
Managers
NameAgeSinceTitle
Yi Fang Wu502016President, CEO & Executive Director
Qi Yu Chen482010Co-Chairman
Fang Yao502017Co-Chairman
Qian Ren50-Chairman-Supervisory Board
Xiao Hui Guan49-CFO, Chief Accountant Officer & Senior VP
Hequn Yin552020Chief Scientific Officer
Yi Min Guan692014Member-Supervisory Board
Gen Xing Cao732008Member-Supervisory Board
Tin Yau Wong, Dr.582015Independent Non-Executive Director
Xian Jiang642015Independent Non-Executive Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,010,958,045 1,045,383,805 52.0% 0 0.0% 62.3%
Stock B 1 551,940,500 551,598,500 99.9% 0 0.0%
Shareholders
NameEquities%
Fosun International Limited 938,095,290 46.6%
China Life Insurance Co Ltd 104,803,492 5.21%
Taikang Asset Management Co., Ltd. 39,301,310 1.95%
E Fund Management Co., Ltd. 20,696,882 1.03%
China Asset Management Co., Ltd. 16,437,317 0.82%
Zhong Ou Asset Management Co., Ltd 11,281,319 0.56%
Anhui State-Owned Assets Sup. & Admin. Commission 8,733,625 0.43%
Harvest Fund Management Co., Ltd. 8,150,664 0.41%
Norges Bank Investment Management 7,752,369 0.39%
Orient Securities Asset Management Co. Ltd. 5,788,147 0.29%
Holdings
NameEquities%Valuation
Shanghai Henlius Biotech, Inc. 289,845,38779.6%1,940,917,751 USD
Sisram Medical Ltd (1696) 330,558,80074.8%117,288,873 USD
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (300452) 25,334,40017.8%94,008,865 USD
New Frontier Health Corporation (NFH) 9,400,0007.16%77,832,000 USD
Hunan Hansen Pharmaceutical Co., Ltd. (002412) 24,263,8204.96%23,975,323 USD
C.Q. Pharmaceutical Holding Co., Ltd. (000950) 21,298,6352.45%15,174,425 USD
Chongqing Jianfeng Chemical Co., Ltd. 14,199,0911.65%10,116,284 USD
EOS imaging (EOSI) 3,446,64913.0%4,800,183 USD
Markets and indexes
- Shanghai Stock Exchange
- B-share
- SSE 50 /
Stock Exchange Codes
- Bloomberg Code :  600196:CH
- Reuters Code :  600196.SS
- Datastream Code :  
Company contact information
Shanghai Fosun Pharmaceutical Group Co., Ltd.
9th Floor 510 Road Caoyang
CN-SH 200063 Shanghai, SH
China

Phone : +86 21 33987000
Fax : +86 21 33987020
Internet : http://www.fosunpharma.com